Cargando…
Iron Metabolism Disturbance in a French Cohort of ALS Patients
Objective. The aim of this study was to assess iron status in a cohort of amyotrophic lateral sclerosis (ALS) patients compared to controls in order to evaluate these parameters as a risk factor or a modifying factor of ALS. Methods. We collected serum iron, ferritin, transferrin, total iron-binding...
Autores principales: | Veyrat-Durebex, Charlotte, Corcia, Philippe, Mucha, Aleksandra, Benzimra, Simon, Mallet, Cindy, Gendrot, Chantal, Moreau, Caroline, Devos, David, Piver, Eric, Pagès, Jean-Christophe, Maillot, François, Andres, Christian R., Vourc'h, Patrick, Blasco, Hélène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101961/ https://www.ncbi.nlm.nih.gov/pubmed/25101285 http://dx.doi.org/10.1155/2014/485723 |
Ejemplares similares
-
Metabolomics: A Tool to Understand the Impact of Genetic Mutations in Amyotrophic Lateral Sclerosis
por: Lanznaster, Débora, et al.
Publicado: (2020) -
Implication of Central Nervous System Barrier Impairment in Amyotrophic Lateral Sclerosis: Gender-Related Difference in Patients
por: Alarcan, Hugo, et al.
Publicado: (2023) -
Study of Ubiquitin Pathway Genes in a French Population with Amyotrophic Lateral Sclerosis: Focus on HECW1 Encoding the E3 Ligase NEDL1
por: Haouari, Shanez, et al.
Publicado: (2023) -
The Roles of NEDD4 Subfamily of HECT E3 Ubiquitin Ligases in Neurodevelopment and Neurodegeneration
por: Haouari, Shanez, et al.
Publicado: (2022) -
Taking Advantages of Blood–Brain or Spinal Cord Barrier Alterations or Restoring Them to Optimize Therapy in ALS?
por: Alarcan, Hugo, et al.
Publicado: (2022)